We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
-$31.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
0.8 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.8 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Top Buys

Rank Stock Value
1
HCP icon
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN icon
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR icon
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO icon
Marathon Oil Corporation
MRO
+$123M
5
CHX icon
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE icon
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS icon
Discover Financial Services
DFS
+$45.1M
4
SCRM icon
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Miscellaneous 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LTC icon
326
LTC Properties
LTC
$2.29B
$719K 0.02%
20,854
-4,071
-16% -$136K
2023 Q1
5 quarters
UTHR icon
327
United Therapeutics
UTHR
$23.6B
$718K 0.02%
2,254
+726
+48% +$192K
2022 Q1
9 quarters
ALLK icon
328
DELISTED
Allakos
ALLK
$717K 0.02%
716,565
+74,900
+12% +$89K
2024 Q1
1 quarter
SPKL
329
DELISTED
Spark I Acquisition Corp
SPKL
$714K 0.02%
68,991
– –
2024 Q1
1 quarter
MLYS icon
330
Mineralys Therapeutics
MLYS
$2.07B
$701K 0.02%
59,931
+1,457
+2% +$18.4K
2023 Q4
2 quarters
MHO icon
331
M/I Homes
MHO
$3.23B
$696K 0.02%
+5,700
New +$697K
2024 Q2
0 quarters
GILD icon
332
Gilead Sciences
GILD
$187B
$686K 0.02%
+10,000
New +$667K
2024 Q2
0 quarters
AURA icon
333
Aura Biosciences
AURA
$678M
$685K 0.02%
90,619
+23,294
+35% +$171K
2023 Q2
4 quarters
HLVX icon
334
DELISTED
HilleVax
HLVX
$679K 0.02%
46,970
+1,294
+3% +$17.8K
2022 Q2
8 quarters
INSM icon
335
CALL
Insmed
INSM
$22B
$677K 0.02%
+60,000
New +$2.33M
2024 Q2
0 quarters
XFOR icon
336
X4 Pharmaceuticals
XFOR
$289M
$673K 0.02%
38,684
-5,833
-13% -$191K
2023 Q2
4 quarters
MU icon
337
Micron Technology
MU
$1.16T
$658K 0.02%
5,000
-20,000
-80% -$2.52M
2023 Q4
2 quarters
THRD icon
338
DELISTED
Third Harmonic Bio
THRD
$640K 0.02%
49,251
+848
+2% +$10.5K
2023 Q3
3 quarters
ARDX icon
339
Ardelyx
ARDX
$847M
$627K 0.02%
84,593
-27,296
-24% -$192K
2023 Q3
3 quarters
INSP icon
340
Inspire Medical Systems
INSP
$1.99B
$614K 0.02%
4,585
-3,500
-43% -$662K
2022 Q3
7 quarters
SLNO icon
341
DELISTED
Soleno Therapeutics
SLNO
$612K 0.02%
+15,000
New +$636K
2024 Q2
0 quarters
ACRV icon
342
Acrivon Therapeutics
ACRV
$81.8M
$610K 0.02%
105,249
-21,700
-17% -$175K
2023 Q2
4 quarters
IRON icon
343
Disc Medicine
IRON
$2.38B
$600K 0.02%
13,319
+10,000
+301% +$340K
2023 Q1
5 quarters
CNTX icon
344
Context Therapeutics
CNTX
$27.9M
$589K 0.02%
293,758
-2,917
-1% -$5.03K
2023 Q2
4 quarters
PYPL icon
345
PayPal
PYPL
$47.5B
$580K 0.02%
10,000
-7,500
-43% -$477K
2023 Q1
5 quarters
BHAC icon
346
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
$577K 0.02%
54,209
– –
2021 Q4
10 quarters
SKIL icon
347
Skillsoft
SKIL
$55.6M
$577K 0.02%
41,692
– –
2023 Q4
2 quarters
BSX icon
348
Boston Scientific
BSX
$61.9B
$547K 0.02%
7,100
-7,700
-52% -$564K
2022 Q1
9 quarters
SABR icon
349
PUT
Sabre
SABR
$767M
$544K 0.02%
+688,600
New +$1.93M
2024 Q2
0 quarters
COTY icon
350
PUT
Coty
COTY
$2.51B
$542K 0.02%
1,264,500
-100,000
-7% -$1.07M
2023 Q3
3 quarters
12 13
14
15 16

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.